Clinical trial
A Double-Blind, Randomized, Placebo and Active-Controlled, Six-Period Crossover Study to Evaluate the Likeability, Safety, and Abuse Liability of NRP104 in Healthy Adult Volunteers With Histories of Stimulant Abuse
NCT00248092 is registered in ClinicalTrials.gov with New River Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Randomized, Placebo and Active-Controlled, Six-Period Crossover Study to Evaluate the Likeability, Safety, and Abuse Liability of NRP104 in Healthy Adult Volunteers With Histories of Stimulant Abuse
- Lead sponsor
- New River Pharmaceuticals
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- May 31, 2006
- Enrollment
- 36
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.